Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Fluarix Tetra New Process
NCT02207413Phase 3Completed
- Sponsor
- GSK
- Start
- Aug 2014
- Primary completion
- Apr 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 7
01
Overview
A Phase 3 trial of Fluarix Quadrivalent in influenza, sponsored by GSK. Started Aug 2014; status: completed.
02
Drugs
Fluarix Quadrivalent
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02207413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02207413.